We are told by customer service that the Miseq v2.2 300-cycle cartridges are back-ordered and the earliest ship date is "mid-August". What are you hearing from your sales rep?
-
-
v2.2?
--
Phillip -
We're still waiting for a v2 300bp Nano kit. Told a week or two.Comment
-
Both our standing order and a new order are delayed until "8/17", they said they are switching their internal database system used for order management, and the 17th is an estimate, like yours. Very annoying to not have any announcement or anything to prepare customers for this.Comment
-
There was an announcement (and an email, but it may have gone to the person who normally does ordering) on icom about the downtime of the ordering system (for the switchover) scheduled for last week of July. Obviously the change was a major one and does not seem to have gone through flawlessly. Hopefully just a matter of time.Comment
-
Ah ok, I guess I'm just out of the loop then.Comment
-
Our 600-cycle kit that was supposed to ship on the 17th showed up today. The 150-cycle kit that was supposed to ship on Monday, hasn't arrived yet.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment